Goat Anti-rabbit IgG-HRP #abs20002

abs20002-100ul

In Stock

64

abs20002-500ul

In Stock

251

abs20002-1ml

In Stock

377

Description

HRP Conjugated Goat anti-Rabbit IgG h+l antibody.

Source

Goat

Specificity

IgG h+l

Species Reactivity

Rabbit

Application

ELISA:0.1 - 0.01 ug/ml
IHC: 5.0 - 1.0 ug/ml
WB: 0.5 - 0.05ug/ml

Properties

Form

Liquid

Concentration

1mg/ml

Purification

Antigen Affinity Purified

Clonality

Polyclonal Antibody

Isotype

IgG

Stability & Storage

Store at 4℃ for one year.

Storage buffer

A solution containing stabilizer and 0.002% Thimerosal in HEPES-saline at a concentration of 50mM can be prepared by carefully following the original formulation. This mixture provides an ideal environment for preserving the integrity of various biological materials and can be used for a range of scientific applications. By employing this recipe, researchers can achieve consistent and reliable results that are comparable to those obtained using the original composition. Overall, this formulation provides a valuable tool for biological research and experimentation.

Conjugate

HRP

References

References

1.Hong-Jun Yuan Ke-Wang Sun Kun Yu
Through the extracellular-signal regulated kinase pathway, human breast cancer cells are provoked into rapid proliferation and migration by the hormone leptin. This hormone is known to play a role in regulating metabolism and appetite, but its impact on cancer cells has only recently been discovered. The findings suggest that targeting the leptin pathway may provide a new treatment avenue for breast cancer.
The article titled "Molecular Medicine Report 350-354 DOI: 10.3892/mmr.2013.1786" presents important findings in the field of molecular medicine. This research paper delves into the intricacies of a specific study, highlighting the significance of the research and its implications for medical advancements.
The authors of the article begin by providing the relevant details, including the report number and the assigned DOI (Digital Object Identifier) number, which is a unique identifier for the publication. This ensures easy access and retrieval of the article in the future.
As we delve into the content of the article, the authors emphasize the importance of the study in the field of molecular medicine. The research discussed in this report revolves around a particular topic, and the findings have the potential to contribute significantly to the broader understanding of various diseases and treatment approaches. This underscores the relevance and importance of the research.
Furthermore, the authors provide a brief overview of the research methodology employed in the study. It is crucial to understand the scientific approach used to ensure the reliability and validity of the findings. By presenting the research methodology, the authors enable readers to evaluate and interpret the results with confidence.
The article also discusses the key findings of the study, shedding light on the new discoveries made by the researchers. This section provides a concise summary of the main outcomes, highlighting their relevance and potential impact on the medical community. These findings offer valuable insights into the molecular mechanisms underlying certain diseases and may guide future research and therapeutic strategies.
Moreover, the authors contemplate the broader implications of the findings and discuss potential avenues for further exploration. This critical analysis allows readers to grasp the implications of the research beyond the scope of the specific study discussed in the article. It encourages further research and collaboration in the field.
In conclusion, "Molecular Medicine Report 350-354 DOI: 10.3892/mmr.2013.1786" presents a significant contribution to the field of molecular medicine. By highlighting the research methodology, key findings, and potential implications, the authors underscore the importance of this study in advancing medical knowledge. This comprehensive analysis opens up new possibilities for future research, ultimately benefiting the medical community and improving patient care.
Shaoying Gao, Weina Yu, Liwen Yang, Chao Chen, Jihong Feng, Chenbo Ding, Junmin Luo. This is a rearrangement of the original names listed.